Page last updated: 2024-12-10

gartanin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gartanin : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, 5 and 8 and prenyl groups at positions 2 and 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281633
CHEMBL ID487992
CHEBI ID5279
SCHEMBL ID1516414

Synonyms (23)

Synonym
gartinin
nsc692946
9h-xanthen-9-one, 1,3,5,8-tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-
1,3,5,8-tetrahydroxy-2,4-bis(3-methylbut-2-enyl)xanthen-9-one
33390-42-0
gartanin
1,3,5,8-tetrahydroxy-2,4-diprenylxanthone
nsc-692946
chebi:5279 ,
CHEMBL487992 ,
bdbm50311743
AKOS016009589
FT-0686620
1,3,5,8-tetrahydroxy-2,4-bis(3-methylbut-2-en-1-yl)-9h-xanthen-9-one
SCHEMBL1516414
Q-100408
DTXSID20187024
1,3,5,8-tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-9h-xanthen-9-one, 9ci
HY-N6038
CS-0032218
Q27106703
mk212hydrochloride
MS-26677
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
xanthonesAny member of the class of xanthenes based on a xanthone skeleton.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
SialidaseClostridium perfringensIC50 (µMol)2.90000.00102.45729.8000AID502478
SialidaseClostridium perfringensKi2.01830.10301.97847.4100AID502476; AID502478
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)IC50 (µMol)20.00000.00011.97318.0000AID468108
Transcription factor p65Homo sapiens (human)IC50 (µMol)19.00000.00011.89818.8000AID468110
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (105)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to lipopolysaccharideNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
apoptotic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
inflammatory responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
JNK cascadeNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of gene expressionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of lipid storageNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of calcidiol 1-monooxygenase activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of vitamin D biosynthetic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of cholesterol transportNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of interleukin-12 productionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
response to muscle stretchNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
non-canonical NF-kappaB signal transductionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of apoptotic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of inflammatory responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
B cell receptor signaling pathwayNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
negative regulation of protein metabolic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
mammary gland involutionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of transcription initiation by RNA polymerase IINuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to mechanical stimulusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to nicotineNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-1Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-6Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to tumor necrosis factorNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to dsRNANuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to interleukin-17Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to virusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
antibacterial innate immune responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of hyaluronan biosynthetic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to angiotensinNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
positive regulation of miRNA metabolic processNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cellular response to stressNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
innate immune responseNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
response to cytokineNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
protein modification processNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
positive regulation of neuron apoptotic processNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
post-translational protein modificationNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
protein neddylationNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
positive regulation of interleukin-1 beta productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
positive regulation of amyloid-beta formationTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
nucleotide-binding oligomerization domain containing 2 signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
liver developmentTranscription factor p65Homo sapiens (human)
hair follicle developmentTranscription factor p65Homo sapiens (human)
defense response to tumor cellTranscription factor p65Homo sapiens (human)
response to ischemiaTranscription factor p65Homo sapiens (human)
acetaldehyde metabolic processTranscription factor p65Homo sapiens (human)
chromatin organizationTranscription factor p65Homo sapiens (human)
DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
inflammatory responseTranscription factor p65Homo sapiens (human)
cellular defense responseTranscription factor p65Homo sapiens (human)
neuropeptide signaling pathwayTranscription factor p65Homo sapiens (human)
canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of cell population proliferationTranscription factor p65Homo sapiens (human)
response to xenobiotic stimulusTranscription factor p65Homo sapiens (human)
animal organ morphogenesisTranscription factor p65Homo sapiens (human)
response to UV-BTranscription factor p65Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionTranscription factor p65Homo sapiens (human)
positive regulation of gene expressionTranscription factor p65Homo sapiens (human)
positive regulation of Schwann cell differentiationTranscription factor p65Homo sapiens (human)
negative regulation of angiogenesisTranscription factor p65Homo sapiens (human)
cytokine-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
protein catabolic processTranscription factor p65Homo sapiens (human)
response to muramyl dipeptideTranscription factor p65Homo sapiens (human)
response to progesteroneTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-12 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-6 productionTranscription factor p65Homo sapiens (human)
positive regulation of interleukin-8 productionTranscription factor p65Homo sapiens (human)
response to insulinTranscription factor p65Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein sumoylationTranscription factor p65Homo sapiens (human)
response to cobalaminTranscription factor p65Homo sapiens (human)
toll-like receptor 4 signaling pathwayTranscription factor p65Homo sapiens (human)
intracellular signal transductionTranscription factor p65Homo sapiens (human)
cellular response to hepatocyte growth factor stimulusTranscription factor p65Homo sapiens (human)
response to muscle stretchTranscription factor p65Homo sapiens (human)
non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
vascular endothelial growth factor signaling pathwayTranscription factor p65Homo sapiens (human)
prolactin signaling pathwayTranscription factor p65Homo sapiens (human)
negative regulation of protein catabolic processTranscription factor p65Homo sapiens (human)
negative regulation of apoptotic processTranscription factor p65Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
response to amino acidTranscription factor p65Homo sapiens (human)
negative regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscription factor p65Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTranscription factor p65Homo sapiens (human)
regulation of inflammatory responseTranscription factor p65Homo sapiens (human)
positive regulation of T cell receptor signaling pathwayTranscription factor p65Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTranscription factor p65Homo sapiens (human)
response to cAMPTranscription factor p65Homo sapiens (human)
defense response to virusTranscription factor p65Homo sapiens (human)
cellular response to hydrogen peroxideTranscription factor p65Homo sapiens (human)
interleukin-1-mediated signaling pathwayTranscription factor p65Homo sapiens (human)
response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to lipopolysaccharideTranscription factor p65Homo sapiens (human)
cellular response to lipoteichoic acidTranscription factor p65Homo sapiens (human)
cellular response to peptidoglycanTranscription factor p65Homo sapiens (human)
cellular response to nicotineTranscription factor p65Homo sapiens (human)
cellular response to interleukin-1Transcription factor p65Homo sapiens (human)
cellular response to interleukin-6Transcription factor p65Homo sapiens (human)
cellular response to tumor necrosis factorTranscription factor p65Homo sapiens (human)
postsynapse to nucleus signaling pathwayTranscription factor p65Homo sapiens (human)
antiviral innate immune responseTranscription factor p65Homo sapiens (human)
negative regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTranscription factor p65Homo sapiens (human)
negative regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
positive regulation of miRNA transcriptionTranscription factor p65Homo sapiens (human)
cellular response to angiotensinTranscription factor p65Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellTranscription factor p65Homo sapiens (human)
positive regulation of miRNA metabolic processTranscription factor p65Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayTranscription factor p65Homo sapiens (human)
cellular response to stressTranscription factor p65Homo sapiens (human)
response to cytokineTranscription factor p65Homo sapiens (human)
innate immune responseTranscription factor p65Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (31)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
chromatin bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
DNA-binding transcription factor activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription coregulator activityNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
protein bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
identical protein bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
actinin bindingNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
ubiquitin-protein transferase activityNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
protein bindingNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
ATP bindingNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
NEDD8 transferase activityNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
NEDD8 conjugating enzyme activityNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
transcription cis-regulatory region bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
transcription coactivator bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscription factor p65Homo sapiens (human)
DNA bindingTranscription factor p65Homo sapiens (human)
chromatin bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor activityTranscription factor p65Homo sapiens (human)
protein bindingTranscription factor p65Homo sapiens (human)
enzyme bindingTranscription factor p65Homo sapiens (human)
protein kinase bindingTranscription factor p65Homo sapiens (human)
chromatin DNA bindingTranscription factor p65Homo sapiens (human)
ubiquitin protein ligase bindingTranscription factor p65Homo sapiens (human)
peptide bindingTranscription factor p65Homo sapiens (human)
phosphate ion bindingTranscription factor p65Homo sapiens (human)
identical protein bindingTranscription factor p65Homo sapiens (human)
protein homodimerization activityTranscription factor p65Homo sapiens (human)
actinin bindingTranscription factor p65Homo sapiens (human)
histone deacetylase bindingTranscription factor p65Homo sapiens (human)
NF-kappaB bindingTranscription factor p65Homo sapiens (human)
ankyrin repeat bindingTranscription factor p65Homo sapiens (human)
general transcription initiation factor bindingTranscription factor p65Homo sapiens (human)
DNA-binding transcription factor bindingTranscription factor p65Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
extracellular regionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
mitochondrionNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytosolNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
secretory granule lumenNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
specific granule lumenNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
chromatinNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
transcription regulator complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
I-kappaB/NF-kappaB complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleusNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
cytoplasmNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
NF-kappaB p50/p65 complexNuclear factor NF-kappa-B p105 subunitHomo sapiens (human)
nucleoplasmNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
cytosolNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
nucleusNEDD8-conjugating enzyme Ubc12Homo sapiens (human)
nucleolusTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
glutamatergic synapseTranscription factor p65Homo sapiens (human)
nucleusTranscription factor p65Homo sapiens (human)
nucleoplasmTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
cytosolTranscription factor p65Homo sapiens (human)
NF-kappaB p50/p65 complexTranscription factor p65Homo sapiens (human)
NF-kappaB complexTranscription factor p65Homo sapiens (human)
chromatinTranscription factor p65Homo sapiens (human)
transcription regulator complexTranscription factor p65Homo sapiens (human)
cytoplasmTranscription factor p65Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID1256913Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID1520351Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166All that glitters is not gold: Panning cytotoxic natural products and derivatives with a fused tricyclic backbone by the estimation of their leadlikeness for cancer treatment.
AID429470Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by agar well diffusion method2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Antimicrobial and immunomodulatory properties of prenylated xanthones from twigs of Garcinia staudtii.
AID399166Antifungal activity against Fusarium oxysporum vasinfectum at 100 ppm after 144 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID689502Antibacterial activity against Salmonella typhimurium TISTR 292 by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID399162Antifungal activity against Drechslera oryzae at 100 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID502478Inhibition of Clostridium perfringens neuraminidase by fluorimetry2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana.
AID378244Cytotoxicity against human CEM-SS cells2000Journal of natural products, Nov, Volume: 63, Issue:11
HIV-Inhibitory prenylated xanthones and flavones from Maclura tinctoria.
AID421811Ratio IC50 for human MCF7 cells to IC50 for chloroquine-resistant Plasmodium falciparum FcB12009Journal of natural products, May-22, Volume: 72, Issue:5
Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea.
AID398909Antifungal activity against Alternaria tenuis at 1000 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID399163Antifungal activity against Drechslera oryzae at 1000 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID468110Inhibition of nuclear factor NF-kappa-B p65 subunit after 1 hr by ELISA2009Journal of natural products, Nov, Volume: 72, Issue:11
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).
AID398910Antifungal activity against Drechslera oryzae at 1 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID689501Antibacterial activity against Escherichia coli TISTR 780 by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID689503Antibacterial activity against methicillin-resistant Staphylococcus aureus SK1 at >128 ug/mL by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID468108Inhibition of p50 after 1 hr by ELISA2009Journal of natural products, Nov, Volume: 72, Issue:11
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).
AID468109Cytotoxicity against human HT-29 cells2009Journal of natural products, Nov, Volume: 72, Issue:11
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).
AID689500Antibacterial activity against Staphylococcus aureus TISTR 1466 by two-fold broth dilution method2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Rearranged benzophenones and prenylated xanthones from Garcinia propinqua twigs.
AID502476Competitive inhibition of Clostridium perfringens neuraminidase by fluorimetry2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana.
AID421810Cytotoxicity against human MCF7 cells assessed as [3H]hypoxanthin incorporation after 24 to 72 hrs2009Journal of natural products, May-22, Volume: 72, Issue:5
Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea.
AID1256912Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
AID502477Inhibition of Clostridium perfringens neuraminidase at 1.56 uM by fluorimetry2010Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17
Xanthones with neuraminidase inhibitory activity from the seedcases of Garcinia mangostana.
AID399165Antifungal activity against Fusarium oxysporum vasinfectum at 10 ppm after 144 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID398908Antifungal activity against Alternaria tenuis at 100 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID421809Antiplasmodial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum FcB1 by [3H]hypoxanthine uptake2009Journal of natural products, May-22, Volume: 72, Issue:5
Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea.
AID378243Antiviral activity against HIV12000Journal of natural products, Nov, Volume: 63, Issue:11
HIV-Inhibitory prenylated xanthones and flavones from Maclura tinctoria.
AID398906Antifungal activity against Alternaria tenuis at 1 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID471089Induction of DR5 promoter activity in SacI gene expressing human DLD1 cells at 10 to 30 uM after 24 hrs by luciferase reporter gene assay relative to control2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Activity of mangosteen xanthones and teleocidin a-2 in death receptor expression enhancement and tumor necrosis factor related apoptosis-inducing ligand assays.
AID398907Antifungal activity against Alternaria tenuis at 10 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID1872494Inhibition of Ubc12 (unknown origin)-neddylation incubated for 30 mins in presence of ATP by Western blot analysis2022European journal of medicinal chemistry, Mar-05, Volume: 231NAE modulators: A potential therapy for gastric carcinoma.
AID399167Antifungal activity against Fusarium oxysporum vasinfectum at 1000 ppm after 144 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID399164Antifungal activity against Fusarium oxysporum vasinfectum at 1 ppm after 144 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID399161Antifungal activity against Drechslera oryzae at 10 ppm after 168 hrs at 24 hrs intervals1997Journal of natural products, May, Volume: 60, Issue:5
Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives.
AID343718Inhibition of aromatase in human placental microsomes at 20 ug/ml relative to control2008Journal of natural products, Jul, Volume: 71, Issue:7
Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's5 (41.67)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.87 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]